These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 16797294)

  • 1. Does cyclosporine have a beneficial effect on the course of chronic hepatitis C infection after renal transplantation?
    Kamar N; Selves J; Sandres-Saune K; Durand D; Izopet J; Rostaing L
    Transplant Proc; 2006 Jun; 38(5):1329-32. PubMed ID: 16797294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The evolution of the hypervariable region-1 of hepatitis C virus may predict liver fibrosis outcome after renal transplantation].
    Kamar N; Rostaing L; Selves J; Sandres-Saune K; Alric L; Durand D; Izopet J
    Nephrol Ther; 2005 Dec; 1(6):345-54. PubMed ID: 16895705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study.
    Delladetsima I; Psichogiou M; Sypsa V; Psimenou E; Kostakis A; Hatzakis A; Boletis JN
    Am J Kidney Dis; 2006 Feb; 47(2):309-16. PubMed ID: 16431260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term evolution of serum and liver viral markers in patients treated for chronic hepatitis C and sustained response.
    Moreno M; Pérez-Alvarez R; Rodrigo L; Pérez-López R; Suárez-Leiva P
    J Viral Hepat; 2006 Jan; 13(1):28-33. PubMed ID: 16364079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
    Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P
    Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
    Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus infection after renal transplantation.
    Romero E; Galindo P; Bravo JA; Osorio JM; Pérez A; Baca Y; Ferreira C; Asensio C; Osuna A
    Transplant Proc; 2008 Nov; 40(9):2933-5. PubMed ID: 19010152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of immunosuppressants on the progression of hepatitis C in hepatitis C virus-positive renal transplantation and the usefulness of interferon therapy.
    Nanmoku K; Imaizumi R; Tojimbara T; Nakajima I; Fuchinoue S; Sakamoto N; Watanabe M; Teraoka S
    Transplant Proc; 2008 Sep; 40(7):2382-5. PubMed ID: 18790241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
    Yilmaz N; Shiffman ML; Stravitz RT; Sterling RK; Luketic VA; Sanyal AJ; Mills AS; Contos MJ; Coterell A; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of immunosuppressive therapy on hepatitis C infection after renal transplantation.
    Kahraman A; Witzke O; Scherag A; Pütter C; Miller M; Dechêne A; Ross SR; Gerken G; Hilgard P
    Clin Nephrol; 2011 Jan; 75(1):16-25. PubMed ID: 21176747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical course of hepatitis C virus infection in renal transplant recipients.
    Savas N; Ocal S; Colak T; Karakayali H; Yilmaz U; Haberal M
    Transplant Proc; 2007 May; 39(4):984-6. PubMed ID: 17524869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttransplant diabetes mellitus in renal transplant patients with hepatitis C virus.
    Sens YA; Silva VD; Malafronte P; Souza JF; Miorin LA; Jabur P
    Transplant Proc; 2004 May; 36(4):886-8. PubMed ID: 15194304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with the intensity of liver fibrosis in renal transplant patients with hepatitis B virus infection.
    Matos CA; Perez RM; Lemos LB; Medina-Pestana JO; Lanzoni VP; Alberto FL; Moreira ES; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):653-7. PubMed ID: 17625434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
    Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
    J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
    Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
    J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus recurrence after liver transplantation: influence of immunosuppressive regimens on viral load and liver histology.
    Oton E; Barcena R; Castillo M; Barreales M; Blesa C; Moreno-Planas JM; Barrios C; Garrido A; Cuervas V
    Transplant Proc; 2006 Oct; 38(8):2499-501. PubMed ID: 17097980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus infection acquired in childhood.
    Camarero C; Ramos N; Moreno A; Asensio A; Mateos ML; Roldan B
    Eur J Pediatr; 2008 Feb; 167(2):219-24. PubMed ID: 17464514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of donor histology on outcome in patients undergoing transplantation for hepatitis C.
    Bahra M; Jacob D; Neumann UP; Spies F; Langrehr JM; Berg T; Neuhaus R; Neuhaus P
    Transplantation; 2007 Jul; 84(2):144-8. PubMed ID: 17667804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.